Back to News
Market Impact: 0.6

Truist reiterates Buy rating on Kinsale Capital stock amid E&S growth

TSLAKNSLSMCIAPP
Analyst InsightsAnalyst EstimatesCorporate EarningsCompany FundamentalsCorporate Guidance & Outlook
Truist reiterates Buy rating on Kinsale Capital stock amid E&S growth

Truist Securities reiterated a Buy rating on Kinsale Capital (KNSL) with a $560 price target, citing management's optimism for faster property insurance market normalization and sustained casualty pricing increases despite competitive pressures. The company, currently trading at $415 and considered undervalued, recently exceeded Q2 2025 earnings and revenue estimates, demonstrating 21% year-over-year revenue growth and maintaining a "GREAT" financial health score. Analysts anticipate material acceleration in Q3 growth, supported by E&S market tailwinds and management's confidence in achieving 10-20% long-term topline growth, reinforcing a positive outlook for the specialty insurer.

Analysis

Kinsale Capital (KNSL) is receiving strong positive sentiment from analysts, underscored by Truist Securities reiterating a Buy rating with a $560 price target, which implies significant upside from its current trading price of $415. This optimism is rooted in management's expectation that property insurance markets will normalize faster than consensus, a view supported by double-digit growth in property premiums in key states during Q3. The company's fundamental strength is evident in its recent performance, including a 21% year-over-year revenue increase and a significant beat on Q2 2025 estimates, with EPS at $4.78 (8.39% surprise) and revenue at $469.81 million (8.5% surprise). While management is confident in its long-term topline growth target of 10-20% and expects casualty pricing to rise, it also acknowledges competitive pressure from managing general agents is a limiting factor. Further bolstering the bull case, Truist's analysis points to a 'material acceleration' in growth for the upcoming third quarter, and BMO Capital has also raised its price target to $477, citing higher net investment income and premiums written.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo